
4 days of survey detects mosquito larvae in nearly 8,000 Nagpur homes
2
Nagpur: A whopping 1,46,509 houses were surveyed across Nagpur in just four days as part of the Nagpur Municipal Corporation (NMC) civic body's intensified campaign to detect mosquito breeding sites.
This translates to an average of 36,627 houses inspected each day by a combined workforce of 1,183 personnel — comprising 1,088 Asha workers and 95 mosquito breeding checkers — working in 8-hour shifts.
On average, each staffer covered approximately 31 houses per day, reflecting the sheer scale and speed of the door-to-door survey launched by the NMC from August 1. The drive, aimed at curbing the spread of dengue, malaria, and chikungunya, found mosquito larvae in 7,986 homes during the initial days of the survey.
A total of 1,088 Asha workers were deployed across the city's 10 zones, with each worker assigned specific localities. Asha workers conducted house-to-house visits to detect mosquito breeding sites such as water coolers, flowerpots, utensils, drums, and discarded containers. Stagnant water in these objects can become breeding grounds for mosquitoes within a week, increasing the risk of disease outbreaks.
The survey work was supported by NMC's 95 mosquito breeding checkers, who also visited households to detect and destroy larvae.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
These Countries Are Known for Being the Least Friendly
BigGlobalTravel
Undo
Apart from conducting regular fogging and spraying, NMC is also running public awareness campaigns to encourage preventive measures.
While the mosquito breeding checkers covered 20,876 houses and found larvae in 853, Asha workers surveyed 1,25,633 homes and detected larvae in 7,133 — revealing the scale of mosquito breeding hotspots across the city. Together, they also inspected 76,680 containers such as water coolers, drums, buckets, and flowerpots, of which 2,575 were found to be contaminated with larvae.
So far, nine cases of dengue and three of chikungunya have been confirmed in the city since July 1. Under the supervision of additional commissioner Vasumana Pant and medical officer Dr Deepak Selokar, the civic body has intensified fogging, spraying, and larvicide application in vulnerable areas, including slums and vacant plots. Mosquito samples are also being tested to identify the diseases they may transmit.
Dr Selokar urged citizens to cooperate with NMC teams and ensure no water is left stagnant around homes. "Public participation is crucial in preventing outbreaks. Every household must stay vigilant," he said.
INFOBOX-1
Survey and Larvae Detection Data (Aug 1–4, 2025):
Mosquito Breeding Checkers: Surveyed 20,876 homes; larvae found in 853 homes
Asha Workers: Surveyed 125,633 homes; larvae found in 7,133 homes
Total Homes Surveyed: 146,509
Total Homes with Larvae: 7,986
INFOBOX-2
Container Inspections (Potential Mosquito Breeding Sources)
By Mosquito Breeding Checkers: 26,992 containers inspected; 415 found contaminated
By Asha Workers: 49,688 containers inspected; 2,160 found contaminated

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
33 minutes ago
- Time of India
7 vs 9 hours of sleep: What's the ideal amount and why it might not be what you think
We've all heard it: 'Get 8 hours of sleep.' But is that really the magic number? For years, health advice has lumped 7 to 9 hours into one big category of 'normal,' leaving most of us guessing where we fall on the sleep scale. Some swear by long weekend lie-ins, while others feel sharp and energised after just seven hours. So which is actually better: 7 or 9 hours of sleep? Can too much sleep be just as risky as too little? And what does science really say about the right amount of rest for your body and brain? New research reveals that seven hours may be the sweet spot for most adults, not just for feeling fresh in the morning, but for long-term health, mental clarity, emotional balance, and even how long you live. Let's break down the science, bust a few myths, and help you figure out your own ideal sleep rhythm. Why seven hours may be the golden number A large study published in Nature Aging examined data from nearly 500,000 adults aged 38 to 73 and uncovered a clear pattern: those who consistently slept for seven hours per night performed significantly better in tests measuring cognitive function, memory, and mental health. Compared to individuals who slept either less or more, the seven-hour sleepers showed sharper attention, quicker processing speed, and more stable moods. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Brain tumor has left my son feeling miserable; please help! Donate For Health Donate Now In contrast, both short and long sleep durations were associated with reduced problem-solving skills, poorer memory recall, and higher levels of anxiety and depression. The findings suggest that even an extra hour or two of sleep beyond the seven-hour mark may not offer added benefits and could actually be linked to declines in brain function and emotional wellbeing. Even the Journal of Clinical Sleep Medicine recommends at least seven hours for adults aged 18 to 60. Consistently getting less than that has been linked to a higher risk of obesity, stroke, Type 2 diabetes, depression, heart disease, and weakened immunity. So why not nine? That's where it gets interesting. Is sleeping nine hours harmful? Not necessarily but it can be a red flag. While an occasional long sleep is fine (like after travel or illness), regularly needing more than nine hours may point to poor sleep quality or an underlying health issue. Studies have shown that long sleepers are at greater risk for: Brain fog and slower mental processing Higher levels of inflammation in the body Mood disorders, especially depression Increased mortality risk in some long-term studies In short: more sleep doesn't automatically mean better health. If you sleep longer and still feel tired, it might be time to look at your sleep hygiene or consult a doctor. What happens if you sleep less than seven? If you're used to burning the midnight oil or waking up early with only 5–6 hours of sleep, your body might be silently suffering, even if you don't feel it right away. Too little sleep, especially over time, can lead to: Weight gain and metabolic issues Poor focus, mood swings, and memory lapses Weakened immune system Higher risk of heart disease and diabetes And no, 'catching up' on the weekend doesn't fully reverse the effects of regular sleep loss. Even if you're clocking in your seven to nine hours of sleep, irregular sleep timing like sleeping at different hours every night or shifting your bedtime drastically on weekends can still wreak havoc on your health. Your body's internal clock, or circadian rhythm, thrives on routine. When that rhythm is disrupted, even the right amount of sleep may not be enough to keep your system in balance. Recent large-scale research has shown that inconsistent sleep and wake times can raise the risk of developing up to 172 different health conditions, ranging from liver damage and metabolic disorders to obesity, type 2 diabetes, and cardiovascular disease. What's more alarming is that even people who technically get enough sleep, say seven or eight hours a night, face a 26% higher risk of heart attacks and strokes if their sleep pattern is erratic. In short, consistency matters just as much as duration, and maintaining a steady sleep schedule could be one of the most underrated health habits you can build. Both 7 and 9 hours can fall into the healthy sleep range but they're not created equal. For most adults, seven hours of consistent, good-quality sleep offers the best mix of mental clarity, physical recovery, and long-term health protection. Instead of just counting hours, pay attention to how you feel, how consistently you sleep, and how well your body performs during the day. Because when it comes to sleep, it's not just about more, it's about smarter. Also read| Why women suffer more from migraines and why doctors often ignore their pain


Time of India
43 minutes ago
- Time of India
Pfizer stock soars as earnings smash expectations, and company raises outlook
PFE stock: Pfizer 's stock rose more than 2% in early trading Tuesday after the pharmaceutical giant reported stronger-than-expected earnings and raised its full-year profit forecast because of the cost-cutting efforts and solid sales of its Covid products and other key drugs, as per a CNBC report. Pfizer's Stock Soars After Raising Profit Forecast The company now expects adjusted earnings per share for 2025 to come in between $2.90 and $3.10, up from its previous guidance of $2.80 to $3, according to the report. Pfizer also maintained its 2025 revenue forecast of $61 billion to $64 billion, as reported by CNBC. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Pfizer CFO David Denton said, 'We raised our full-year 2025 Adjusted diluted EPS guidance, demonstrating confidence in our ability to execute against our strategic priorities and deliver strong results for shareholders,' as quoted in the CNBC report. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 20 Pieces of Clothing Older Women should Avoid Learn More ALSO READ: Plastic Treaty 2025: Will world leaders finally address the $1.5 trillion health crisis in Geneva? How Pfizer Is Handling Political Pressure on Drug Prices The firm's upbeat outlook comes despite the challenges posed by US political pressure to lower drug prices, including tariffs and potential pricing reforms advocated by US president Donald Trump, as per the CNBC report. The company factored in these headwinds, along with a one-time $1.35 billion charge related to a licensing deal for its cancer treatment outside China, which will hit its third-quarter results, according to the report. Live Events Pfizer's Q2 Results Surprise Wall Street in a Big Way Investors were encouraged by Pfizer's second-quarter performance, which blew past Wall Street's expectations, as per the CNBC report. Adjusted earnings per share came in at 78 cents, which was well above the 58 cents analysts predicted, as reported by CNBC. Revenue also surged 10% year-over-year to $14.65 billion, according to the CNBC report. ALSO READ: As the July jobs report paints a grim picture, 114 companies plan layoffs in August - is yours on the list? Pfizer's Covid Products Lead Revenue Growth Behind the growth were Pfizer's Covid products, including its Comirnaty vaccine, which saw a 96% revenue increase from last year because of a larger market share and more international contracts, as per the CNBC report. The company's antiviral pill Paxlovid also posted strong sales, which rose 70% from the prior year despite fewer Covid infections worldwide, according to the CNBC report. Other drugs like Vyndaqel, used to treat heart muscle disease, as well as bladder cancer treatment Padcev and blood thinner Eliquis, contributed to the positive sales momentum, as per the report. However, the company faced headwinds from its breast cancer drug Ibrance, which saw lower US prices due to Medicare reforms and generic competition, according to the CNBC report. Pfizer's Cost-Cutting Plans to Boost Profits The second quarter results come after the firm in April increased its cost-cutting efforts, which aim to help the pharmaceutical firm recover from the rapid decline of its Covid business and stock price over the past few years, as per the report. Along with the added cuts announced in April, the company now expects to deliver around $7.7 billion in savings by the end of 2027 from two separate cost-cutting program, as reported by CNBC. FAQs What helped Pfizer's revenue grow this quarter? Mostly its Covid vaccine and antiviral pill, along with strong sales from other drugs like heart and cancer treatments, as per the CNBC report. What's Pfizer doing to cut costs? They've ramped up cost-cutting programs and expect to save about $7.7 billion by the end of 2027, as per the CNBC report.


Time of India
an hour ago
- Time of India
Chikungunya virus spreading fast in China - is it reaching pandemic level? Here're causes, symptoms and treatment
Chikungunya virus spreading fast in China : The southern province of Guangdong is seeing thousands of infections as a result of China's unexpected chikungunya virus outbreak. Public anxiety has increased due to the rapid spread, which has drawn comparisons to the early stages of COVID-19. Although there is no human-to-human transmission of the virus, things are quickly shifting. What's fueling the surge in China? Since July, Guangdong province in China has reported more than 7,000 cases of the chikungunya virus, leading to similar actions as during the Covid-19 pandemic. In Foshan City, patients are required to remain in hospitals, protected by mosquito nets, and are only allowed to leave once their tests come back negative or after a week-long stay. The virus can cause years-long fever and excruciating joint pain. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Chikungunya outbreaks are frequent in South and Southeast Asia as well as some regions of Africa, but they are uncommon in China. Nearly 3,000 infections have been reported in the past week alone, with at least 12 additional cities in the southern Guangdong province reporting cases, as quoted in a report by BBC. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like According to officials, 95% of patients were released within seven days, and all cases that were reported were mild. However, because the virus is not well known in the nation, the cases have caused some panic. In light of the outbreak, the US has advised travellers to travel with "increased caution". ALSO READ: iPhone 17 release date confirmed, Apple promises its most powerful iPhone ever - here's what fans can expect Live Events How bad are the symptoms, and who is most likely to get them? The virus usually makes you tired, gives you a fever, a rash, headache, swollen joints, muscular soreness and joint pain. Most people get better in a week, but some people have joint pain that lasts for months or years. The elderly, those with underlying medical disorders including diabetes or heart disease, and newborns are among those at risk for more severe disease. What steps is China taking right now to stop the spread? Local governments have started aggressive campaigns to get rid of mosquitoes. If people don't get rid of standing water in and around their homes, they could be fined up to 10,000 yuan. People are using drones to find water sources, and they have put thousands of fish that eat mosquitoes into lakes. Officials are also using big "elephant mosquitoes" to find and kill mosquitoes that carry chikungunya. Two cities in southeastern China have encouraged visitors returning from afflicted areas to keep an eye out for symptoms of the mosquito-borne disease, while the southern city of Foshan has mandated real-name registration for medications used to treat chikungunya fever. How can people who travel keep chikungunya from getting them? People who are going to areas where there is an outbreak should wear long sleeves, use an EPA-approved insect repellent, and sleep under mosquito nets if they need to. Prevention & Treatment of Chikungunya Prevention Since no specific antiviral therapy is available, the main goal of treatment for chikungunya is symptom relief. It is recommended that patients take analgesics and antipyretics to control their fever and pain, rest, and drink plenty of water. ALSO READ: Poop showdown! Furious farmers drench squatters with manure to reclaim their land - video goes viral In suspected cases of chikungunya, it is critical to rule out dengue because effective treatment of dengue can dramatically lower complications and mortality. For people who have chronic joint pain, physical therapy, corticosteroids, and NSAIDs may help, as per a report by CDC Health. Treatment The main goal of chikungunya prevention is to reduce mosquito exposure, particularly for visitors to endemic areas. EPA-registered insect repellents, protective clothing, and accommodations with air conditioning or screens should all be recommended to people. Two vaccines are available in the United States for individuals who are more susceptible, such as certain travelers and laboratory workers, making vaccination another effective preventive measure. There are two vaccines that you can get right now: IXCHIQ is a live-attenuated vaccine for adults 18 and older. VIMKUNYA is a virus-like particle vaccine for people 12 and older. The CDC says not to use IXCHIQ in people 60 and older until more research is done because there have been reports of bad effects in older adults. People with chikungunya should also limit their exposure to mosquitoes during the first week of their illness in order to avoid local transmission. Experts say that the outbreak in China is worrying, but it hasn't reached the level of a pandemic yet. Getting rid of it is only possible with mosquito control, early diagnosis, and public awareness. FAQs Is chikungunya contagious among humans? No, chikungunya is transmitted only through mosquito bites, not through human-to-human contact. Can you get a chikungunya vaccine before traveling? Yes, two vaccines (IXCHIQ and VIMKUNYA) are approved for use in the United States for specific age groups.